The invention includes liquid formulations of botulinum toxin that are stableto storage in liquid form at standard refrigerator temperatures for at least 1-2 years and to storage at higher temperatures for at least 6 months. Theinvention also includes methods of treatment using such formulations and usesof such formulations in the manufacture of medicaments for various therapeuticand cosmetic treatments.